From FreightWaves, March 22:
Ozempic slims America — and it’s lightening truckers’ loads!
The freight market is no stranger to disruptive forces — tariffs, recessions, weather, economic fluctuations, and capacity crunches have all reshaped freight demand over the years. But a new contender is emerging from an unexpected corner: the widespread adoption of GLP-1 medications (think Ozempic, Wegovy, Mounjaro, and similar GLP-1 receptor agonists).
These drugs, originally developed for diabetes management and now massively popular for weight loss, suppress appetite and reduce overall caloric intake. Early estimates suggest that even at current penetration levels — roughly 12% of U.S. adults — the downstream effect on food and beverage demand could be substantial.
Recent analyses, drawing from academic studies out of Purdue, Cornell, and others (including 2025 updates), point to an approximate 3% drop in total caloric food demand due to appetite suppression. That may sound modest, but in the context of America’s food supply chain, the numbers scale quickly.
U.S. trucks move more than 2 billion tons of food and beverages annually. At an average payload of around 20 tons per truckload, that’s roughly 100 million+ truckloads per year dedicated to food and bev freight.
Apply a 3% reduction across that volume, and you’re looking at approximately 3 million fewer truckloads annually....
....MUCH MORE
And thus doing more to cut carbon dioxide emissions than most partisan policy prescriptions.
